Related Experiment Video

Updated: Aug 11, 2026

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

An engineer's approach to the development of real anti-aging medicine

Aubrey D N J de Grey1

  • 1Department of Genetics, University of Cambridge, Downing Street, Cambridge CB2 3EH, UK. ag24@gen.cam.ac.uk

Science of Aging Knowledge Environment : SAGE KE
|July 8, 2003
PubMed

Insights

This viewpoint discusses age-related molecular and cellular changes limiting lifespan. It proposes a problem-solving strategy to reverse these changes, potentially increasing healthy human life expectancy.

Area of Science:

  • Gerontology and Molecular Biology
  • Cellular Aging Research

Background:

  • Mammalian lifespan is limited by accumulating molecular and cellular damage.
  • These age-related changes are precursors to various pathologies.

Purpose of the Study:

  • To identify key age-related molecular and cellular changes.
  • To propose a strategic approach for reversing these detrimental changes.

Main Methods:

  • Review and synthesis of current research on aging.
  • Development of a problem-solving framework for intervention.

Main Results:

  • Identification of multiple molecular and cellular hallmarks of aging.
  • Outline of a systematic approach to target these aging processes.

Conclusions:

  • Reversing age-related molecular and cellular damage is a viable strategy.
  • This approach may prevent age-related diseases and extend healthy lifespan.

More Related Videos

Laboratory Scale Production and Purification of a Therapeutic Antibody09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

Related Concept Videos

Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...